CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Edesa Biotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Edesa Biotech Inc
100 Spy Crt
Phone: (905) 475-1234p:905 475-1234 MARKHAM, ON  L3R 5H6  Canada Ticker: EDSAEDSA

Business Summary
Edesa Biotech Inc., Stellar Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for dermatological and gastrointestinal indications. The Company’s lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis. The Company has its operations in the United States and in Canada.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20199/30/2018YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of Board SeanMacDonald 42 6/7/2019 6/7/2019
President Michael J.Brooks 41 6/7/2019 6/7/2019
Chief Executive Officer, Director PardeepNijhawan 48 6/7/2019 6/7/2019
6 additional Officers and Directors records available in full report.

Business Names
Business Name
BioEstelar, S.A. de C.V.
Edesa Biotech, Inc.
EDSA
SBOT
Stellar Biotechnologies, Inc.

General Information
Number of Employees: 25 (As of 11/28/2018)
Outstanding Shares: 7,504,468 (As of 8/14/2019)
Stock Exchange: NASD
Fax Number: (905) 475-1234


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 15, 2019